Entering text into the input field will update the search result below

Immuron nabs European patent for NASH treatment; shares up 9% premarket

Jul. 24, 2018 8:36 AM ETImmuron Limited (IMRN) StockBy: Douglas W. House, SA News Editor1 Comment
  • Ultra-thinly traded nano cap Immuron Limited (NASDAQ:IMRN) is up 9% premarket on light volume on the heels of its announcement that the European Patent Office has issued it a patent covering the use of its enriched immunoglobulin preparation derived from colostrum for the treatment of nonalcoholic steatohepatitis (NASH).
  • The patent will be in effect until April 2030.

Recommended For You

About IMRN Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
IMRN--
Immuron Limited